Literature DB >> 1540944

Inhibition of proliferation by retinoids, cytokines and their combination in four human transformed epithelial cell lines.

W Bollag1, R Peck, J R Frey.   

Abstract

Various combinations of retinoids and cytokines were examined for their synergistic effect on inhibition in proliferation of four human transformed epithelial cell lines, MCF7 (mammary carcinoma), SCC4, SCC15 and A431 (squamous cell carcinomas). Synergism depended on the cell line tested, to some degree on the specific retinoid but particularly on the type of cytokine used. IFN alpha had the widest spectrum of activity. IFN gamma, TNF-alpha, IL-1, EGF and TGF-beta also exerted a synergistic effect on proliferation inhibition in certain cell lines, whereas G-CSF was inactive. Association of retinoids and cytokines represents a new approach to antitumor chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540944     DOI: 10.1016/0304-3835(92)90188-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

1.  An Eastern Cooperative Oncology Group phase I trial of all-trans-retinoic acid and interferon-alpha: E2Y92.

Authors:  J H Schiller; D Neuberg; D Burns; P Ritch; M Larson; M Levitt; J Dutcher
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

2.  Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells.

Authors:  J Corbeil; E Rapaport; D D Richman; D J Looney
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

3.  Multimodality bronchoscopic imaging of recurrent respiratory papillomatosis.

Authors:  Henri G Colt; Septimiu D Murgu; Bockhyun Jung; Yeh-Chan Ahn; Matt Brenner
Journal:  Laryngoscope       Date:  2010-03       Impact factor: 3.325

4.  Inhibition of estrogen-responsive gene activation by the retinoid X receptor beta: evidence for multiple inhibitory pathways.

Authors:  J H Segars; M S Marks; S Hirschfeld; P H Driggers; E Martinez; J F Grippo; M Brown; W Wahli; K Ozato
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.